Trials / Completed
CompletedNCT03507400
Introvision for Migraine and Headaches
Treatment of Migraine With Introvision, a Method of Mental Self-regulation - IntroMig: Randomised Waiting-list Control Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- Ludwig-Maximilians - University of Munich · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the effect of Introvision, a mental and emotional self-regulation-technique developed by Angelika C. Wager, as migraine preventative compared to a waiting list group.
Detailed description
Randomized, single-center, waiting-list control group study: Introvision as preventative in Migraine Randomized, single center, waiting-list group control study to evaluate the effect of Introvison, a mental and emotional self regulation method to reduce headache days in patients with migraine, migraine and tension type headache and chronic migraine. The number of headache days 3 months after completion of the last session of Introvision will be compared with the number of headache days of the waiting list group in the month before the course to learn Introvision.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Introvision: mental and emotional self-regulation | Participants learn Introvision |
Timeline
- Start date
- 2017-09-20
- Primary completion
- 2019-09-11
- Completion
- 2020-07-19
- First posted
- 2018-04-25
- Last updated
- 2025-04-18
- Results posted
- 2025-04-18
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03507400. Inclusion in this directory is not an endorsement.